Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness and Safety of Restylane Lyft Lidocaine for Jawline Definition

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female adults willing to comply with the requirements of the study and providing a signed written informed consent~* Consent the use of facial images for marketing purposes and educational material~* Subject with moderate to very severe (Grade 2 to 4) on the GJS~* Subject is willing to abstain from any other facial, submental, and/or neck aesthetic procedure(s) or implant~* Female of childbearing potential with a negative urine pregnancy test before treatment~Exclusion Criteria:~* Subjects presenting with known/previous allergy or hypersensitivity to hyaluronic acid (HA) filler, lidocaine or other amide-type local anesthetics~* Subjects presenting with known/previous allergy or hypersensitivity to streptococcal proteins~* Subject with bleeding disorders or taking thrombolytics or anticoagulants~* Prior surgical procedure in the treatment area~* History of other facial treatment/procedure in the previous 6 months HA in or near the intended treatment site~* Presence of any disease or lesions near or on the area to be treated~* Presence of any condition, in the opinion of the Treating Investigator, makes the subject unable to complete the study per protocol~* Women who are pregnant or breast feeding, or women of childbearing potential who are not practicing adequate contraception or planning to become pregnant during the study period~* Study site personnel, close relatives of the study site personnel, employees, or close relatives of employees at the Sponsor Company~* Participation in any other interventional clinical study within 30 days before treatment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Treatment group (Type: EXPERIMENTAL): Initial Restylane Lyft Lidocaine injection and one optional touch-up treatment at 1 month after treatment
- No-treatment control group (Type: NO_INTERVENTION): Optional treatment will be administered at 12 months

Based on this trial design, predict the completion outcome and termination type (if applicable).